WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Thursday, 29 January 2015

WWARN launches new tool to monitor parasite clearance

Thursday, 29 January 2015

New collaboration to distinguish inadequate lumefantrine exposure from resistance

Thursday, 29 January 2015

Enhancing scientific cooperation

Thursday, 29 January 2015

Unique tool combines results of malaria studies around the world

Thursday, 29 January 2015

Strengthening the practical value of molecular resistance markers in public health

Thursday, 29 January 2015

Mekong Molecular Surveillance Network strengthens efforts to combat drug resistance

Thursday, 29 January 2015

New resistance emerging in SE Asia

Thursday, 29 January 2015

Responding to regional challenges in Africa

Thursday, 29 January 2015

Building the WWARN community in Africa

Thursday, 22 January 2015

Grant Dorsey, University of California

Thursday, 22 January 2015

Genetic architecture of resistance

Study identifies 26 independent mutations on the kelch 13 gene, from 15 different locations in Southeast Asia, were associated with a delayed rate of malaria parasite clearance – a clear indicator of malaria drug resistance.
Tuesday, 9 December 2014

WHO releases World Malaria Report 2014

Monday, 8 December 2014

Spread of antimalarial molecular resistance to sulphadoxine-pyrimethamine

Monday, 8 December 2014

Antimalarial Drug Treatment Policy Developments in Africa

Monday, 8 December 2014

Philippe Guérin Suggests Data Management Could Support Antibiotic Resistance Research

Monday, 8 December 2014

New Genome Sequencing Technologies Detect Populations of Malaria-Resistant Parasites

Monday, 8 December 2014

Candidate Markers of Delayed P. Falciparum Clearance After Artemisinin Treatment

Thursday, 4 December 2014

WWARN appeals for worldwide cooperation to beat spread of antimalarial resistance

Thursday, 4 December 2014

WWARN launched with BMGF grant

Thursday, 27 November 2014

Antimalarial drug resistance: at what cost?